505
Views
5
CrossRef citations to date
0
Altmetric
Special Review Series

GPIb-IX-V and platelet clearance

ORCID Icon
Pages 817-822 | Received 19 Jan 2021, Accepted 09 Jun 2021, Published online: 23 Jun 2021

References

  • Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012;120(15):e73–82. doi:10.1182/blood-2012-04-416594
  • Modderman PW, Admiraal LG, Sonnenberg A. von dem Borne AE. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. JBC 1992;267(1):364–369. doi:10.1016/S0021-9258(18)48503-1
  • Luo SZ, Mo X, Afshar-Kharghan V, Srinivasan S, Lopez JA, Li R. Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet. Blood 2007;109(2):603–609. doi:10.1182/blood-2006-05-024091
  • Mo X, Liu L, Lopez JA, Li R. Transmembrane domains are critical to the interaction between platelet glycoprotein V and glycoprotein Ib-IX complex. J Thrombosis Haemostasis 2012;10(9):1875–1886. doi:10.1111/j.1538-7836.2012.04841.x
  • Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996;84(2):289–297. doi:10.1016/S0092-8674(00)80983-6
  • Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8(11):1227–1234. doi:10.1038/nm1102-1227
  • Bernard J, Soulier J. On a new variety of congenital thrombocytary hemo-ragiparous dystrophy. Sem Hop 1948;24:3217–3223.
  • Jenkins CS, Phillips DR, Clemetson KJ, Meyer D, Larrieu MJ, Luscher EF. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand’s disease. J Clin Invest 1976;57(1):112–124. doi:10.1172/JCI108251
  • Zhang W, Deng W, Zhou L, Xu Y, Yang W, Liang X, Wang Y, Kulman JD, Zhang XF, Li R, et al. Identification of a juxtamembrane mechanosensitive domain in the platelet mechanosensor glycoprotein Ib-IX complex. Blood 2015;125(3):562–569. doi:10.1182/blood-2014-07-589507
  • Deng W, Xu Y, Chen W, Paul DS, Syed AK, Dragovich MA, Liang X, Zakas P, Berndt MC, Di Paola J, et al. Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor. Nat Commun 2016;7(1):12863. doi:10.1038/ncomms12863
  • Quach ME, Dragovich MA, Chen W, Syed AK, Cao W, Liang X, Deng W, De Meyer SF, Zhu G, Peng J, et al. Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets. Blood 2018;131(7):787–796. doi:10.1182/blood-2017-05-784975
  • Du X, Harris SJ, Tetaz TJ, Ginsberg MH, Berndt MC. Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. JBC 1994;269(28):18287–18290. doi:10.1016/S0021-9258(17)32301-3
  • Calverley DC, Kavanagh TJ, Roth GJ. Human signaling protein 14-3-3zeta interacts with platelet glycoprotein Ib subunits Ibalpha and Ibbeta. Blood 1998;91(4):1295–1303. doi:10.1182/blood.V91.4.1295
  • Mazzucato M, Pradella P, Cozzi MR, De Marco L, Ruggeri ZM. Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor. Blood 2002;100(8):2793–2800. doi:10.1182/blood-2002-02-0514
  • Ju L, Chen Y, Xue L, Du X, Zhu C. Cooperative unfolding of distinctive mechanoreceptor domains transduces force into signals. Elife 2016:5.
  • Garcia A, Quinton TM, Dorsam RT, Kunapuli SP. Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets. Blood 2005;106(10):3410–3414. doi:10.1182/blood-2005-05-1933
  • Wu Y, Asazuma N, Satoh K, Yatomi Y, Takafuta T, Berndt MC, Ozaki Y, et al. Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase. Blood 2003;101(9):3469–3476. doi:10.1182/blood-2002-03-0806
  • Mangin P, Yuan Y, Goncalves I, Eckly A, Freund M, Cazenave J-P, Gachet C, Jackson SP, Lanza F, et al. Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. JBC 2003;278(35):32880–32891. doi:10.1074/jbc.M302333200
  • Yap CL, Anderson KE, Hughan SC, Dopheide SM, Salem HH, Jackson SP. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3). Blood 2002;99(1):151–158. doi:10.1182/blood.V99.1.151
  • Li Z, Zhang G, Feil R, Han J, Du X. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3. Blood 2006;107(3):965–972. doi:10.1182/blood-2005-03-1308
  • Li J, van der Wal DE, Zhu G, Xu M, Yougbare I, Ma L, Vadasz B, Carrim N, Grozovsky R, Ruan M, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun 2015;6(1):7737. doi:10.1038/ncomms8737
  • Yan R, Chen M, Ma N, Zhao L, Lijuan C, Zhang Y, Zhang J, Yu Z, Wang Z, Xia L, et al. Glycoprotein Ibalpha clustering induces macrophage-mediated platelet clearance in the liver. Thromb Haemost 2015;113(1):107–117. doi:10.1160/TH14-03-0217
  • Okumura I, Lombart C, Jamieson GA. Platelet glycocalicin. II. Purification and characterization. JBC 1976;251(19):5950–5955. doi:10.1016/S0021-9258(17)33044-2
  • Liang X, Russell SR, Estelle S, Jones LH, Cho S, Kahn ML, Berndt MC, Bunting ST, Ware J, Li R, et al. Specific inhibition of ectodomain shedding of glycoprotein Ibalpha by targeting its juxtamembrane shedding cleavage site. J Thromb Haemost 2013;11(12):2155–2162. doi:10.1111/jth.12425
  • Chen W, Liang X, Syed AK, Jessup P, Church WR, Ware J, Josephson CD, Li R, et al. Inhibiting GPIbα shedding preserves post-transfusion recovery and hemostatic function of platelets after prolonged storage. Arterioscler Thromb Vasc Biol 2016;36(9):1821–1828. doi:10.1161/ATVBAHA.116.307639
  • Casari C, Du V, Wu YP, Kauskot A, de Groot PG, Christophe OD, Denis CV, de Laat B, Lenting PJ, et al. Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia. Blood 2013;122(16):2893–2902. doi:10.1182/blood-2013-03-493312
  • Gangarosa EJ, Landerman NS, Rosch PJ, Herndon EG Jr. Hematologic complications arising during ristocetin therapy; relation between dose and toxicity. N Engl J Med 1958;259(4):156–161. doi:10.1056/NEJM195807242590402
  • Sanders WE, Read MS, Reddick RL, Garris JB, Brinkhous KM. Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin. An animal model. Lab Invest 1988;59(4):443–452.
  • Grozovsky R, Begonja AJ, Liu K, Visner G, Hartwig JH, Falet H, Hoffmeister KM, et al. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med 2015;21(1):47–54. doi:10.1038/nm.3770
  • Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, Nizet V, Marth JD. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008;14(6):648–655. doi:10.1038/nm1760
  • Sorensen AL, Rumjantseva V, Nayeb-Hashemi S, Clausen H, Hartwig JH, Wandall HH, Hoffmeister KM. Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood 2009;114(8):1645–1654. doi:10.1182/blood-2009-01-199414
  • Hudgin RL, Pricer WE Jr., Ashwell G, Stockert RJ, Morell AG. The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins. JBC 1974;249(17):5536–5543. doi:10.1016/S0021-9258(20)79761-9
  • Drickamer K, Mamon JF, Binns G, Leung JO. Primary structure of the rat liver asialoglycoprotein receptor. Structural evidence for multiple polypeptide species. JBC 1984;259(2):770–778. doi:10.1016/S0021-9258(17)43524-1
  • Solum NO, Hagen I, Filion-Myklebust C, Stabaek T. Platelet glycocalicin. Its membrane association and solubilization in aqueous media. Biochim Biophys Acta 1980;597(2):235–246. doi:10.1016/0005-2736(80)90102-9
  • Grewal PK, Aziz PV, Uchiyama S, Rubio GR, Lardone RD, Le D, Varki NM, Nizet V, Marth JD, et al. Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor. Proc Natl Acad Sci U S A 2013;110(50):20218–20223. doi:10.1073/pnas.1313905110
  • Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sørensen AL, Larson G, Marth JD, Hartwig JH, Hoffmeister KM, et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med 2009;15(11):1273–1280. doi:10.1038/nm.2030
  • Lodish HF. Recognition of complex oligosaccharides by the multi-subunit asialoglycoprotein receptor. Trends Biochem Sci 1991;16(10):374–377. doi:10.1016/0968-0004(91)90154-N
  • Wang Y, Chen W, Zhang W, Lee-Sundlov MM, Casari C, Berndt MC, Lanza F, Bergmeier W, M. Hoffmeister K, Zhang XF, et al. Desialylation of O-glycans on glycoprotein Ibα drives receptor signaling and platelet clearance. Haematologica 2020;106(1):220–229. Epub ahead of print. doi:10.3324/haematol.2019.240440
  • Riswari SF, Tunjungputri RN, Kullaya V, Garishah FM, Utari GSR, Farhanah N, Overheul GJ, Alisjahbana B, Gasem MH, Urbanus RT, et al. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue. PLoS Pathog 2019;15(3):e1007500. doi:10.1371/journal.ppat.1007500
  • Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007;5(7):1530–1537. doi:10.1111/j.1538-7836.2007.02590.x
  • Bergmeier W, Piffath CL, Cheng G, et al. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo. Circ Res 2004;95(7):677–683. doi:10.1161/01.RES.0000143899.73453.11
  • Bergmeier W, Burger PC, Piffath CL, Hoffmeister KM, Hartwig JH, Nieswandt B, Wagner DD, et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood 2003;102(12):4229–4235. doi:10.1182/blood-2003-04-1305
  • Zhang XF, Zhang W, Quach ME, Deng W, Force-Regulated LR. Refolding of the mechanosensory domain in the platelet glycoprotein Ib-IX complex. Biophys J 2019;116(10):1960–1969. doi:10.1016/j.bpj.2019.03.037
  • Tao ZF, Hasvold L, Wang L, Wang X, Petros AM, Park CH, Boghaert ER, Catron ND, Chen J, Colman PM, et al. Discovery of a Potent and Selective BCL-X L Inhibitor with in Vivo Activity. ACS Med Chem Lett 2014;5(10):1088–1093. doi:10.1021/ml5001867
  • Wagner KU, Claudio E, Rucker EB 3rd, Riedlinger G, Broussard C, Schwartzberg PL, Siebenlist U, Hennighausen L, et al. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development 2000;127(22):4949–4958. doi:10.1242/dev.127.22.4949
  • Kodama T, Takehara T, Hikita H, Shimizu S, Shigekawa M, Li W, Miyagi T, Hosui A, Tatsumi T, Ishida H, et al. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets. JBC 2011;286(16):13905–13913. doi:10.1074/jbc.M110.195370
  • Nesbitt WS, Kulkarni S, Giuliano S, Goncalves I, Dopheide SM, Yap CL, Harper IS, Salem HH, Jackson SP, et al. Distinct glycoprotein Ib/V/IX and integrin alpha IIbbeta 3-dependent calcium signals cooperatively regulate platelet adhesion under flow. JBC 2002;277(4):2965–2972. doi:10.1074/jbc.M110070200
  • Fujii T, Sakata A, Nishimura S, Eto K, Nagata S. TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets. Proc Natl Acad Sci U S A 2015;112(41):12800–12805. doi:10.1073/pnas.1516594112
  • Li S, Wang Z, Liao Y, ZHANG W, SHI Q, YAN R, RUAN C, DAI K, et al. The glycoprotein Ibα-von Willebrand factor interaction induces platelet apoptosis. J Thrombosis Haemostasis 2010;8(2):341–350. doi:10.1111/j.1538-7836.2009.03653.x
  • Murphy S, Gardner FH. Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest 1971;50(2):370–377. doi:10.1172/JCI106504
  • Hartley PS, Savill J, Brown SB. The death of human platelets during incubation in citrated plasma involves shedding of CD42b and aggregation of dead platelets. Thromb Haemost 2006;95(1):100–106. doi:10.1160/TH05-06-0403
  • Michelson AD, Adelman B, Barnard MR, Carroll E, Handin RI. Platelet storage results in a redistribution of glycoprotein Ib molecules. Evidence for a large intraplatelet pool of glycoprotein Ib. J Clin Invest 1988;81(6):1734–1740. doi:10.1172/JCI113513
  • Kostelijk EH, Folman CC, Gouwerok CW, Kramer CM, Verhoeven AJ, de Korte D. Increase in glycocalicin levels in platelet concentrates stored in plasma or synthetic medium for 8 days: comparison with other platelet activation markers. Vox Sang 2000;79(1):21–26. doi:10.1046/j.1423-0410.2000.7910021.x
  • Canault M, Duerschmied D, Brill A, Stefanini L, Schatzberg D, Cifuni SM, Bergmeier W, Wagner DD, et al. p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood 2010;115(9):1835–1842. doi:10.1182/blood-2009-03-211706
  • Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability--deleterious effect of refrigerated storage. N Engl J Med 1969;280(20):1094–1098. doi:10.1056/NEJM196905152802004
  • Jansen AJ, Josefsson EC, Rumjantseva V, Liu QP, Falet H, Bergmeier W, Cifuni SM, Sackstein R, von Andrian UH, Wagner DD, et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice. Blood 2012;119(5):1263–1273. doi:10.1182/blood-2011-05-355628
  • Josefsson EC, Gebhard HH, Stossel TP, Hartwig JH, Hoffmeister KM. The macrophage alphaMbeta2 integrin alphaM lectin domain mediates the phagocytosis of chilled platelets. JBC 2005;280(18):18025–18032. doi:10.1074/jbc.M501178200
  • Badlou BA, Spierenburg G, Ulrichts H, Deckmyn H, Smid WM, Akkerman JW. Role of glycoprotein Ibα in phagocytosis of platelets by macrophages. Transfusion 2006;46(12):2090–2099. doi:10.1111/j.1537-2995.2006.01034.x
  • Chen W, Druzak SA, Wang Y, et al. Refrigeration-Induced Binding of von Willebrand Factor Facilitates Fast Clearance of Refrigerated Platelets. Arterioscler Thromb Vasc Biol 2017;37(12):2271–2279. doi:10.1161/ATVBAHA.117.310062
  • Becker BH, Miller JL. Effects of an antiplatelet glycoprotein Ib antibody on hemostatic function in the guinea pig. Blood 1989;74(2):690–694. doi:10.1182/blood.V74.2.690.690
  • Cadroy Y, Hanson SR, Kelly AB, Marzec UM, Evatt BL, Kunicki TJ, Montgomery RR, Harker LA, et al. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood 1994;83(11):3218–3224. doi:10.1182/blood.V83.11.3218.3218
  • Bergmeier W, Rackebrandt K, Schroder W, Zirngibl H, Nieswandt B. Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies. Blood 2000;95(3):886–893. doi:10.1182/blood.V95.3.886.003k45_886_893
  • Webster ML, Sayeh E, Crow M, Chen P, Nieswandt B, Freedman J, Ni H, et al. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies. Blood 2006;108(3):943–946. doi:10.1182/blood-2005-06-009761
  • Harrington WJ, Minnich V, Hollingsworth JW, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951;38(1):1–10.
  • Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci 1998;19(3):237–244. doi:10.1016/S0955-3886(98)00037-X
  • Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, Zirngibl H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 2000;96(7):2520–2527. doi:10.1182/blood.V96.7.2520
  • Zeng Q, Zhu L, Tao L, Bao J, Yang M, Simpson EK, Li C, van der Wal DE, Chen P, Spring CM, et al. Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbalpha antibodies. Am J Hematol 2012;87(2):206–208. doi:10.1002/ajh.22211
  • Peng J, Ma S-H, Liu J, Hou Y, Liu X-M, Niu T, Xu -R-R, Guo C-S, Wang X-M, Cheng Y-F, et al. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. J Thromb Haemost 2014;12(4):497–504. doi:10.1111/jth.12524
  • Cauwenberghs N, Meiring M, Vauterin S, van Wyk V, Lamprecht S, Roodt JP, Novak L, Harsfalvi J, Deckmyn H, Kotze HF, et al. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates. Arterioscler Thromb Vasc Biol 2000;20(5):1347–1353. doi:10.1161/01.ATV.20.5.1347
  • Slayter H, Loscalzo J, Bockenstedt P, Handin RI. Native conformation of human von Willebrand protein. Analysis by electron microscopy and quasi-elastic light scattering. JBC 1985;260(14):8559–8563. doi:10.1016/S0021-9258(17)39509-1
  • Deng W, Wang Y, Druzak SA, et al. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor. 15(9):1867-1877.
  • Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996;88(8):2939–2950. doi:10.1182/blood.V88.8.2939.bloodjournal8882939
  • Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand’s disease. N Engl J Med 1980;302(19):1047–1051. doi:10.1056/NEJM198005083021902
  • Cooney KA, Ginsburg D. Comparative analysis of type 2b von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets. Blood 1996;87(6):2322–2328. doi:10.1182/blood.V87.6.2322.bloodjournal8762322
  • Lillicrap D. Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood 2013;122(23):3735–3740. doi:10.1182/blood-2013-06-498303
  • Bury L, Malara A, Momi S, Petito E, Balduini A, Gresele P. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease. Haematologica 2019;104(7):1473–1481. doi:10.3324/haematol.2018.200378
  • Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, Lopez JA, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002;100(12):4033–4039. doi:10.1182/blood-2002-05-1401
  • Arya M, Anvari B, Romo GM, Cruz MA, Dong J-F, McIntire LV, Moake JL, Lopez J, et al. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 2002;99(11):3971–3977. doi:10.1182/blood-2001-11-0060
  • Larkin D, de Laat B, Jenkins PV, et al. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog 2009;5(3):e1000349. doi:10.1371/journal.ppat.1000349

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.